ArticleCombinatorial chemistry & high throughput screening2026
Network Pharmacology and Transcriptomic Analysis Reveal the Therapeutic Mechanisms of Xiebai Bining Decoction in Hyperuricemic Nephropathy.
Article in Combinatorial chemistry & high throughput screening, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionT cell exhaustion plays a critical role in the progression of hyperuricemic nephropathy. Xiebai Bining Decoction can alleviate hyperuricemic nephropathy. However, the precise multi-target mechanisms underlying its therapeutic benefits remain unclear. Therefore, the study aimed to elucidate the potential mechanisms by which Xiebai Bining Decoction regulates T cell exhaustion in hyperuricemic nephropathy and identify novel molecular targets for precise traditional Chinese medicine (TCM)-based interventions.
methodsNetwork pharmacology was used to predict the active compounds and potential targets of Xiebai Bining Decoction based on oral bioavailability and drug-likeness. Transcriptomic data from a hyperuricemic nephropathy mouse model were used to validate and expand these predictions.
resultsIntegrated network pharmacology and transcriptomic analyses revealed the key biological processes, including regulation of T cell activation, negative regulation of T cell activation, and negative regulation of defense responses, as well as enriched pathways. DISCUSSION: The integrated approach effectively revealed the molecular mechanisms underlying the therapeutic effects of the TCM Xiebai Bining Decoction in hyperuricemic nephropathy. These findings highlight the immunoregulatory effects of Xiebai Bining Decoction, particularly its ability to attenuate T cell exhaustion, and suggest promising molecular targets for targeted intervention. Additional clinical and mechanistic studies are warranted to validate these findings further and develop effective therapies for hyperuricemic nephropathy.
conclusionThis study elucidated the therapeutic mechanisms of Xiebai Bining Decoction in hyperuricemic nephropathy, including key pathways involved in T cell exhaustion, immune modulation, and renal protection.
Indexed as
Identifiers
41820319What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.